Final analysis of European patients from the Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of its Treatment with Sorafenib (GIDEON) study: Baseline characteristics and staging systems.

Abstract

4088 Background: The global, prospective, non-interventional GIDEON study recruiting >3,000 patients with unresectable hepatocellular carcinoma treated with sorafenib is complete. We report the fin...